
England: A remarkable development in breast cancer research has revealed a fundamental mechanism behind driving cancer invasion and drug resistance.
A University of Liverpool study reveals how two critical molecules present in 'HER2-positive' breast cancer - one of the most aggressive forms - influence breast cancer survival and its spread.